$5.3 Million Debt and Equity Investment

Steel Partners

We represented Steel Partners in connection with its $5.3 million combined debt and equity investment in Ore Pharmaceuticals. As part of the transaction, Steel Partners received the right to nominate two new directors to replace two current directors, who resigned in conjunction with the transaction.

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.